OSBP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.626000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.911000E-01
Normal-vs-Stage2
5.571000E-01
Normal-vs-Stage3
1.138030E-01
Normal-vs-Stage4
3.545600E-01
Stage1-vs-Stage2
6.876000E-01
Stage1-vs-Stage3
3.818000E-02
Stage1-vs-Stage4
6.166000E-01
Stage2-vs-Stage3
5.466100E-02
Stage2-vs-Stage4
3.000600E-01
Stage3-vs-Stage4
1.234600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.102400E-01
Normal-vs-AfricanAmerican
1.675750E-01
Normal-vs-Asian
7.279200E-01
Caucasian-vs-AfricanAmerican
4.527700E-02
Caucasian-vs-Asian
8.859600E-01
AfricanAmerican-vs-Asian
1.548440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.756200E-01
Normal-vs-Female
5.617600E-01
Male-vs-Female
7.899600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.549400E-01
Normal-vs-Age(41-60Yrs)
2.741200E-01
Normal-vs-Age(61-80Yrs)
7.114200E-01
Normal-vs-Age(81-100Yrs)
8.436600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.799420E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.333800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.874200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.031680E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.282380E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.107000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.577800E-01
Normal-vs-Daily Drinker
8.916600E-01
Normal-vs-Weekly Drinker
8.220800E-01
Normal-vs-Occasional Drinker
2.209400E-01
Normal-vs-Social Drinker
2.314400E-01
Non Drinker-vs-Daily Drinker
6.730000E-01
Non Drinker-vs-Weekly Drinker
5.684400E-01
Non Drinker-vs-Occasional Drinker
4.323600E-03
Non Drinker-vs-Social Drinker
2.555900E-02
Daily Drinker-vs-Weekly Drinker
8.706400E-01
Daily Drinker-vs-Occasional Drinker
3.479900E-02
Daily Drinker-vs-Social Drinker
1.286800E-01
Weekly Drinker-vs-Occasional Drinker
8.375600E-02
Weekly Drinker-vs-Social Drinker
2.113600E-01
Occasional Drinker-vs-Social Drinker
4.556000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.229830E-01
Normal-vs-Grade 2
4.719900E-02
Normal-vs-Grade 3
1.297520E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.998600E-01
Grade 1-vs-Grade 3
4.611400E-01
Grade 1-vs-Grade 4
1.229830E-01
Grade 2-vs-Grade 3
3.503600E-01
Grade 2-vs-Grade 4
4.719900E-02
Grade 3-vs-Grade 4
1.297520E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.094200E-01
Normal-vs-NonDiabetic
5.509600E-01
Diabetic-vs-NonDiabetic
1.464450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.576200E-01
Normal-vs-NoPancreatitis
6.548400E-01
Pancreatitis-vs-NoPancreatitis
5.607600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.888400E-01
Normal-vs-N1
5.490800E-01
N0-vs-N1
9.946400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.466430E-01
Normal-vs-TP53-NonMutant
3.491000E-01
TP53-Mutant-vs-TP53-NonMutant
2.492200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
